author-photo

Ashok Panneerselvam

Exelixis

3

Papers

2

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Cabozantinib in Combination With Atezolizumab for Advanced Renal Cell Carcinoma: Results From the COSMIC-021 Study

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
LBA24 Cabozantinib (C) in combination with atezolizumab (A) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Results of expanded cohort 6 of the COSMIC-021 study

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
A phase III, randomized, open-label, study (CONTACT-02) of cabozantinib plus atezolizumab versus second novel hormone therapy (NHT) in patients (pts) with metastatic, castration-resistant prostate cancer (mCRPC).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)